middle.news
Cynata Completes Phase 2 Enrolment for Promising aGvHD Therapy
9:17am on Monday 15th of December, 2025 AEDT
•
Healthcare
Read Story
Cynata Completes Phase 2 Enrolment for Promising aGvHD Therapy
9:17am on Monday 15th of December, 2025 AEDT
Key Points
65 patients enrolled across US, Europe, and Australia
Trial compares steroids plus CYP-001 against steroids plus placebo
Primary endpoint, Overall Response Rate at Day 28
Results expected by June 2026
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Cynata Therapeutics (ASX:CYP)
OPEN ARTICLE